Can Newer Therapies Delay the Progression of Type 2 Diabetes Mellitus?
Year: 2008
Type: review
Source: Endocrine Practice
DOI: 10.4158/ep.14.5.625
Author: Edward S. Horton
Institution: Joslin Diabetes Center
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Eli Lilly and Company, Novo Nordisk
OpenAlex ID: W2116617876